MASSMUTUAL TRUST CO FSB/ADV - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 28 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$13,700
+10.1%
4,8240.0%0.00%
Q3 2023$12,446
-40.3%
4,8240.0%0.00%
-100.0%
Q2 2023$20,840
+182.3%
4,8240.0%0.00%
Q1 2023$7,381
+92162.5%
4,8240.0%0.00%
Q4 2022$8
-99.9%
4,8240.0%0.00%
Q3 2022$6,000
-40.0%
4,8240.0%0.00%
Q2 2022$10,000
-16.7%
4,8240.0%0.00%
Q1 2022$12,000
-33.3%
4,8240.0%0.00%
-100.0%
Q4 2021$18,000
-5.3%
4,8240.0%0.00%0.0%
Q3 2021$19,0004,8240.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Manatuck Hill Partners, LLC 267,300$1,326,0000.62%
Worth Venture Partners, LLC 132,514$657,0000.36%
WEXFORD CAPITAL LP 400,000$1,984,0000.23%
Eidelman Virant Capital 35,000$173,0000.09%
Granite Point Capital Management, L.P. 229,970$1,141,0000.08%
Patriot Financial Group Insurance Agency, LLC 2,000$10,0000.00%
GABLES CAPITAL MANAGEMENT INC. 125$1,0000.00%
FNY Investment Advisers, LLC 521$2,0000.00%
MILLENNIUM MANAGEMENT LLC 99,340$493,0000.00%
TORONTO DOMINION BANK 48$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders